摘要:
Methods are provided for use in open surgical and transluminal methods for supplying long-term retrograde perfusion of the myocardium via a conduit disposed between the left ventricle and the coronary sinus. In a first method, an opening is formed between the left ventricle and the coronary sinus, and the coronary ostium is partially occluded using a stent that prevents the pressure in the coronary sinus from exceeding a predetermined value. In an alternative method, a first end of a conduit is inserted transeptally through the right atrium and obliquely into the posterior septal endocardium of the left ventricle via the posterior pyramidal space, while a second end of the conduit is inserted into the coronary sinus via the coronary ostium. A pressure-limiting valve is included in the conduit. In either method, the outlet from the left ventricle to the coronary sinus may include a one-way valve to prevent backflow from the coronary sinus into the left ventricle during cardiac diastole.
摘要:
This invention provides compounds having the structure ##STR1## wherein R is hydrogen, alkyl, alkenyl, alkynyl, --COR.sup.2, phenyl, or phenylalkyl; the dotted line represents an optional double bond;R.sup.1 is hydrogen, --OH, OR.sup.3, or is absent if the optional double bond is present;R.sup.2 and R.sup.3 are each, independently, alkyl, alkenyl, alkynyl, phenyl, or phenylalkyl;R.sup.4 is hydrogen, --OR.sup.5, alkyl, alkenyl, alkynyl, --COR.sup.5, --CO.sub.2 R.sup.5, --CONR.sup.5 R.sup.6, perhaloalkyl, halogen, phenyl, or phenylalkyl;R.sup.5 and R.sup.6 are each, independently, hydrogen, alkyl, alkenyl, alkynyl, phenyl, or phenylalkyl; andn=0-2or a pharmaceutically acceptable salt thereof that are useful as antipsychotic, antidepressant and anxiolytic agents useful in the treatment and relief of the symptoms of these disease states.
摘要翻译:本发明提供了具有结构“IMAGE”的化合物,其中R是氢,烷基,烯基,炔基,-COR 2,苯基或苯基烷基; 虚线表示可选的双键; R1是氢,-OH,OR3,如果存在任选的双键,则不存在; R2和R3各自独立地为烷基,烯基,炔基,苯基或苯基烷基; R 4是氢,-OR 5,烷基,烯基,炔基,-COR 5,-CO 2 R 5,-CONR 5 R 6,全卤代烷基,卤素,苯基或苯基烷基; R 5和R 6各自独立地为氢,烷基,烯基,炔基,苯基或苯基烷基; 和n = 0-2或其药学上可接受的盐,其可用作抗精神病药,抗抑郁药和抗焦虑剂,其用于治疗和缓解这些疾病状态。
摘要:
There are disclosed substituted benzoylbenzene-, biphenyl- and 2-oxazole- alkanoic acid derivatives and the pharmacologically acceptable salts thereof as inhibitors of PLA.sub.2 and lipoxygenase, and their use in the treatment of inflammatory conditions, such as rheumatoid arthritis, ulcerative colitis, psoriasis and other immediate hypersensitivity reactions; in the treatment of leukotriene-mediated naso-bronchial obstructive air-passageway conditions, such as allergic rhinitis, allergic bronchial asthma and the like; and as gastric cytoprotective agents.
摘要:
There are disclosed compounds of the formulaA(CH.sub.2).sub.n O-BwhereinA is C.sub.4 -C.sub.8 alkyl, phenoxyethyl, phenoxyphenyl or a group having the formula ##STR1## wherein ##STR2## R.sup.1 is hydrogen, lower alkyl, phenyl or phenyl substituted with trifluoromethyl;R.sup.2 is hydrogen or lower alkyl; orR.sup.1 and R.sup.2 taken together form a benzene ring;R.sup.3 is hydrogen or lower alkyl;n is 1-2;B is ##STR3## wherein ##STR4## m is 0-3; R.sup.5 is ##STR5## or phenyl or phenyl substituted by halo, lower alkylthio, lower alkylsulfinyl or lower alkylsulfonyl;R.sup.6 is A(CH.sub.2).sub.n O-- or halo; with the proviso that when R.sup.6 is halo, R.sup.5 is ##STR6## R.sup.7 is lower alkyl; Y is --CH.sub.2 -- or --O--;R.sup.8 is lower alkyl or --(CH.sub.2).sub.m CO.sub.2 R.sup.3 ;R.sup.9 is ##STR7## or --CH.sub.2 R.sup.10 ; R.sup.10 is lower alkyl, phenyl, phenyl substituted with carboxy, halo, loweralkylthio or loweralkylsulfinyl, pyridyl, furanyl or quinolinyl;R.sup.11 is lower alkyl or phenyl;Z is hydrogen, lower alkyl or --N(CH.sub.3)OH;and the pharmacologically acceptable salts thereof, and their use in the treatment of inflammatory conditions, such as rheumatoid arthritis, ulcerative colitis, psoriasis and other immediate hypersensitivity reactions; in the treatment of leukotriene-mediated naso-bronchial obstructive air-passageway conditions, such as allergic rhinitis, allergic bronchial asthma and the like; and as gastric cytoprotective agents.
摘要:
Hepatobiliary magnetic resonance imaging of a human or animal subject is enhanced by enterally administering to the subject an effective amount of a lipophilic contrast enhancing agent. Representative contrast enhancing agents include manganese mesoporphyrin, manganese deuteroporphyrin, manganese pheophorbide and manganese pyrophenophoribide, and, when administered orally, an enteric delivery agent.
摘要:
The disclosure is directed to a method and apparatus for generating a processed image of a cross-section through a body. Fluoroscopic tomography is achieved wherein a series of video frames of a cross-section of a body can be viewed in real time. In this manner, for example, one can monitor the progress of a bolus of contrast material moving through a blood vessel in the cross-section being viewed. In a form of the disclosure, a recorded series of frames of a principal plane of a body being imaged can be processed to obtain a corresponding series of frames that represent a plane of interest that is spaced from the principal plane, thereby avoiding the necessity of re-exposure for each new plane to be viewed. In accordance with the disclosed method, a body is disposed between a combination of a source of radiation and an associated detector, such that a beam of radiation from the source impinges angularly on the body and passes through to the detector. Relative rotational motion is effected between the beam and the body, such that a principal plane of interest in the body remains substantially in focus during the relative rotational motion. A series of frames of electronic video signals are derived from the detector, at different rotational positions, the frames representing images of the radiation transmission characteristics of the body at a series of successive times. The series of frames are temporally filtered and then displayed. In a preferred embodiment, the temporal filtering step comprises filtering the series of frames of video signals with a filter function having a temporal frequency response that corresponds substantially the temporal frequency of the movement of a bolus of contrast material through the region being imaged.
摘要:
The cannula of a conventional intravascular catheter is placed into the peritoneal cavity through a small shallow incision in antiseptically prepared skin. The stylet or trocar of the conventional catheter is removed; and a stainless steel elongated flexible guide is inserted through the catheter's cannula into the peritoneal cavity. The catheter's cannula is removed and a flexible elongated cannula inserted into the cavity over the guide and secured in place with a suture. Fluid operation means is connected to the elongated cannula by connector means to permit fluid treatment after removal of the guide. Apparatus to effect peritoneal fluid treatment are placed in sterile openable sealed packages for storage and transport.
摘要:
An improved catheter is provided for insertion into a trachea, blood vessel, bladder or urinary tract of a patient. The self cleaning catheter can be easily inserted and removed from the patient without retained, solid components falling into a patient's trachea, blood vessels, bladder, or urinary tract when the catheter is removed from the patient. The self cleaning catheter has a flexible cylindrical sleeve on the exterior of a cylindrical member that can be withdrawn to the interior of the catheter prior to removal from the patient's body. Alternatively, the catheter has a design allowing an end of the catheter to fold inward on itself prior to removal from the patient's body.
摘要:
This invention provides compounds of the formulae: wherein: R1 is hydrogen, —C(O)CH3 or alkyl of 1-6 carbon atoms; R2 and R3 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, cycloalkyl, alkoxy of 1-6 carbon atoms, —CH2OH, fluoroalkyl, alkyl sulfonamide of 1-6 carbon atoms, alkyl amide of 1-6 carbon atoms, amino, alkylamino of 1-6 carbon atoms, dialkylamino of 1-6 carbon atoms per alkyl moiety, fluoroalkoxy of 1-6 carbon atoms, acyl of 2-7 carbon atoms, aryl, or aroyl; R4 and R5 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, halogen, fluoroalkyl, —CN, alkyl sulfonamide of 1-6 carbon atoms, alkyl amide of 1-6 carbon atoms, amino, alkylamino of 1-6 carbon atoms, dialkylamino of 1-6 carbon atoms per alkyl moiety, fluoroalkoxy of 1-6 carbon atoms, acyl of 2-7 carbon atoms, or aroyl; R6 and R7 are each independently hydrogen, C1-C6 alkyl or cycloalkyl; or a pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions containing these compounds and methods for their use, including treatment of obsessive-compulsive disorder, panic disorder, depression, anxiety, generalized anxiety disorder, schizophrenia, migraine, sleep disorders, eating disorders, obesity, epilepsy, and spinal cord injury.
摘要翻译:本发明提供下式的化合物:其中:R 1是氢,-C(O)CH 3或1-6个碳原子的烷基; R 2和R 3各自独立地为氢,1-6个碳原子的烷基,环烷基,1-6个碳原子的烷氧基,-CH 2 1-6个碳原子的烷基磺酰胺,1-6个碳原子的烷基酰胺,1-6个碳原子的烷基氨基,1-6个碳原子的烷基氨基,每个烷基部分1-6个碳原子的二烷基氨基,1个碳原子的氟代烷氧基 -6个碳原子,2-7个碳原子的酰基,芳基或芳酰基; R 4和R 5各自独立地为氢,1-6个碳原子的烷基,1-6个碳原子的烷氧基,卤素,氟烷基,-CN,烷基 1-6个碳原子的磺酰胺,1-6个碳原子的烷基酰胺,1-6个碳原子的烷基氨基,每个烷基部分1-6个碳原子的二烷基氨基,1-6个碳原子的氟烷氧基,2- 7个碳原子或芳酰基; R 6和R 7各自独立地为氢,C 1 -C 6烷基或环烷基; 或其药学上可接受的盐,以及含有这些化合物的药物组合物及其使用方法,包括治疗强迫症,恐慌症,抑郁症,焦虑症,广泛性焦虑症,精神分裂症,偏头痛,睡眠障碍,进食障碍, 肥胖,癫痫和脊髓损伤。
摘要:
A paint roller assembly includes a wire frame having a spindle on which a wire cage is rotatably mounted with end mounting bearing members. An outermost bearing member includes an annular wall provided with a flexible arm having a stop at its distal end. The stop normally abuts an end of a tubular paint roller to lock same against lengthwise movement. A paint barrier on the bearing member defines an area for momentary reception of the arm and stop during roller removal and installation procedures.